Neonatal hypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinal fluid

Clinica Chimica Acta

Volumn 450, Issue , 2015, Pages 282-297

  Lv, Hongyan ^a   Wang, Qiuli ^a   Wu, Sujing ^a   Yang, Lihong ^a   Ren, Pengshun ^a   Yang, Yihui ^b   Gao, Jinsheng ^b   Li, Lianxiang ^a,b  

^a Handan City Maternal and Child Health Hospital   (China)

^b HEBEI UNIVERSITY OF ENGINEERING   (China)

Author keywords

Biomarker; Cerebrospinal fluid; Hypoxic ischemic encephalopathy; Newborn; Serum

Indexed keywords

ACTIVIN A; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; CREATINE KINASE BB; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; HIGH SENSITIVITY C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; LACTATE DEHYDROGENASE; MALONALDEHYDE; MICRORNA; MYELIN BASIC PROTEIN; NEURON SPECIFIC ENOLASE; PADGEM PROTEIN; PROTEIN S100B; SUPEROXIDE DISMUTASE; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN CARBOXYL TERMINAL HYDROLASE L1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; DISABILITY; EARLY DIAGNOSIS; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; METABOLISM; NERVE INJURY; NERVOUS SYSTEM INFLAMMATION; NERVOUS TISSUE; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SERUM; ANIMAL; BLOOD;

ANIMALS; BIOMARKERS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN;

EID: 84944163398     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.08.021     Document Type: Review

References (116)

1. Gieron-Korthals M., Colón J.H. Hypoxic-ischemic encephalopathy in infant: new challenges. Fetal Pediatr. Pathol. 2005, 24:105-120.
2. Lai M.C., Yang S.N. Perinatal hypoxic-ischemic encephalopathy. J. Biomed. Biotechnol. 2011, 2011:609813.
3. Buonocore G., Perrone S., Longini M., et al. Non protein bound iron as early predictive marker of neonatal brain damage. Brain 2003, 126:1224-1230.
4. Cai Q., Xue X.D., Fu J.H. Research status and progress of neonatal hypoxic ischemic encephalopathy. Chin. J. Pract. Pediatr. 2009, 24:968-971.
5. Vanucci R.C., Perlman J.M. Intervention for perinatal hypoxic-ischemic encephalopathy. Pediatrics 1997, 100:1004-1014.
6. Okeda R. Concept and pathogenesis of "hypoxic-ischemic encephalopathy". Acta Neurochir. Suppl. 2003, 86:3-6.
7. Mao J. The etiology and pathogenesis of neonatal hypoxic ischemic encephalopathy. Chin. J. Gen. Pract. 2009, 8:7-9.
8. Disefano G., Praticò A.D. Actualities on molecular pathogenesis and repairing processes of cerebral damage in perinatal hypoxic-ischemic encephalopathy. Ital. J. Pediatr. 2010, 16:63.
9. Cai Y.J., Song Y.Y., Liu Q., et al. Effects of erythropoietin on myelin basic protein and neurological behavior in P3 neonatal rats with white matter damage. Chin. J. Neonatol. 2013, 28:264-268.
10. Radulova P., Slancheva B. Neonatal hypoxic-ischemic brain injury: pathogenesis and neuropathology. Akush. Ginekol. (Sofiia) 2014, 53:41-47.
11. Thornton C., Rousset C.I., Kichev A., et al. Molecular mechanisms of neonatal brain injury. Neurol. Res. Int. 2012, 2012:506320.
12. Thoresen M., Hellstrǒm-Westas L., Liu X., et al. Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia. Pediatrics 2010, 126:e131-e139.
13. Celtik C., Acunas B., Oner N., et al. Neuron-specific enolase as a marker of the severity and outcome of hypoxic encephalopathy. Brain Dev. 2004, 26:398-402.
14. Liu C.Y., Dong W.B., Chen Y., et al. The relationship between serum neuron specific and neonatal hypoxic ischemic encephalopathy. Chin. J. Birth Health Hered. 2005, 13:85-86.
15. Yang J.L., Zhu C.L., Zhang G.Z., et al. The relationship between the changes of serum neuron specific and the prognosis of neonatal hypoxic ischemic encephalopathy. Chin. J. Pediatr. 1997, 36:320-321.
16. Feng X., You H.Q., Yao Y.F., et al. The changes and its significance of neuron specific enolase in the newborn hypoxic ischemic encephalopathy. Chin. J. Pract. Pediatr. 1997, 12:343-344.
17. Douglas-Escobar M., Weiss M.D. Biomarkers of hypoxic-ischemic encephalopathy in newborns. Front. Neurol. 2012, 2:144.
18. Roka A., Kelen D., Halasz J., et al. Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia. Acta Paediatr. 2012, 101:319-323.
19. Barbrese E., Barry C., Chou C.H., et al. Expression and localization of myelin basic protein in oligodendrocytes and transfected fibroblasts. J. Neurochem. 1988, 51:1737-1745.
20. Waigt A., Górny M. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies. Acta Neurol. Scand. 1983, 68:337-345.
21. Davies L., McLeod J.G., Muir A., et al. Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness. Clin. Exp. Neurol. 1987, 24:5-7.
22. Petersson K.H., Pinar H., Stopa E.G., et al. White matter injury after cerebral ischemia in ovine fetuses. Pediatr. Res. 2002, 51:768-778.
23. Hu S.J., Cheng Y.W., Han Z.L., et al. Serum level of mylin basic protein in hypoxic-ischemic encephalopathy neonates. Acta Acad. Med. Qingdao Univ. 2009, 45:63-64.
24. Sun Y.L., Meng L., Guo J.L., et al. Relationship between serum myelin basic protein and neonatal hypoxic ischemic encephalopathy. Chin. J. Birth Health Hered. 2007, 15:16-17.
25. Qian J., Zhou D., Wang Y.W. Umbilical artery blood S100 beta protein: a tool for the early identification of neonatal hypoxic-ischemic encephalopathy. Eur. J. Pediatr. 2009, 168:71-77.
26. Kapural M., Krizanac-Bengez L., Barnett G., et al. Serum S100B as a possible marker of blood-brain barrier disruption. Brain Res. 2002, 94:102-104.
27. Nagdyman N., Kǒmen W., Ko H.K., et al. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr. Res. 2001, 49:502-506.
28. Pei X.M., Gao R., Zhang G.Y., et al. Effects of erythropoietin on serum NSE and S-100 β levels in neonates with hypoxic ischemic encephalopathy. Chin. J. Contemp. Pediatr. 2014, 16:705-708.
29. Chen Y.M., Fan Z.G., Huang J.G. S-100β protein in the neonatal hypoxic ischemic encephalopathy in the clinical application. J. Med. Theor. Pract. 2009, 22:767-771.
30. Gazzolo D., Pluchinotta F., Bashir M., et al. Neurological abnormalities in full-term asphyxiated newborns and salivary S100 β testing: the "Cooperative multitask against brain injury of neonates"(CoMBINe)international study. PLoS One 2015, 10.
31. Florio P., Abella R., Marinoni E., et al. Biochemical markers of perinatal brain damage. Front. Biosci. (Schol. Ed.) 2010, 2:47-72.
32. Sulliva S.M., Bjǒrkman S.T., Miller S.M., et al. Morphological changes in white matter astrocytes in response to hypoxia/ischemia in the neonatal pig. Brain Res. 2010, 1319:164-174.
33. Chalak L.K., Sánchez P.J., Adams-Huet B., et al. Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy. J. Pediatr. 2014, 164:468-474.
34. Ennen C.S., Huisman T.A., Savage W.J., et al. Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling. Am. J. Obstet. Gynecol. 2011, 205(251):e1-e7.
35. Thompson R.J., Doran J.F., Jackson P., et al. PGP 9.5-a new marker for vertebrate neurons and neuroendocrine cells. Brain Res. 1983, 278:224-228.
36. Schofield J.N., Dayl N., Thompson R.J., et al. PGP 9.5, a ubiquitin C-terminal hydrolase: pauem of mRNA and protein expression during neural development in the mouse. Brain Res. Dev. Brain Res. 1995, 85:224-228.
37. Day I.N., Thompson R.J. UCHL1 (PGP 9.5): Neuronal biomarker and ubiquitin system protein. Prog. Neurobiol. 2010, 90:327-362.
38. Zhang W., Su P., Kuang Z.Z. Application value-Li in early identification of acute ischemic cerebrovascular disease. Shandong Med. J. 2013, 53:15-17.
39. Brophy G.M., Mondello S., Papa L., Tepas J., Buki A., Robertson C., Tortella F.C., Hayes R.L., Wang K.K., et al. Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in servere traumatic brain injury patient biofuids. J. Neurotrauma 2011, 28:861-870.
40. Douglas-Escobar M.V., Heaton S.C., Bennett J., et al. UCH-L1 and GFAP Serum Levels in Neonates with Hypoxic-Ischemic Encephalopathy: A Single Center Pilot Study. Front. Neurol. 2014, 5:273.
41. Jiang S.H., Wang J.X., Zhang Y.M., et al. Effect of hypothermia therapy on serum GFAP and UCH-L1 levels in neonates with hypoxic-ischemic encephalopathy. Chin. J. Contemp. Pediatr. 2014, 16:1193-1196.
42. Douglas-Escbar M.V., Heaton S.C., Bennett J., et al. UCH-L1 and GFAP serum levels in neonates with hypoxic-ischemic encephalopathy: a single center pilot study. Front. Neurol. 2014, 5:273.
43. Chouthai N., Sampers N., Desai N., et al. Changes in neurotrophin levels in umbilical cord blood from infant with different gestational age and clinical conditions. Pediatr. Res. 2003, 53:965-969.
44. Imam S.S., Gad G.I., Aterf S.H., et al. Gord blood brain derived neurotrophic factor: diagnostic and prognostic marker in full-term newborns with perinatal asphyxia. Pak. J. Biol. Sci. 2009, 12:1498-1504.
45. Liu M.D., Luo P., Wang Z.J., et al. Changes of serum Tau, GFAP, TNF-α and malonaldehyde after blast-related traumatic brain injury. Chin. J. Traumatol. 2014, 17:317-322.
46. Nurullah O., Canan T., Eray E.O., et al. Tau and s-100B proteins as biochemical markers of bilirubin-induced neurotoxicity in term neonates. Pediatr. Neurol. 2008, 39:245-250.
47. Cui H., Yang L. Analysis of microRNA expression detected by microarray of the cerebral cortex after hypoxic-ischemic brain injury. J. Craniomaxillofac. Surg. 2013, 24:2147-2152.
48. Hua Y.J., Tang Z.Y., Tu K., et al. Identification and target prediction of miRNAs specifically expressed on rat neural tissue. BMC Genomics 2012, 10:214-220.
49. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNA: are the answers in sight?. Nat. Rev. Genet. 2008, 9:102-114.
50. Zhang Y., Guo J. MicroRNA and cerebral ischemic injury. Acta Acad. Med. Sci. 2012, 34:418-421.
51. Weiss J.B., Eisenhardt S.U., Stark G.B., et al. MicroRNAs in ischemia-reperfusion injury. Am. J. Cardiovasc. Dis. 2012, 2:237-247.
52. Chen H., Yang T.T. expression and significance of serum miRNA-21 control HIF-1a in newborn with asphyxia. Chin. J. Child Health Care 2015, 23:32-34.
53. He J.T., Mang J., Mei C.L., et al. Neuroprotective effects of exogenous activin A on oxygen-glucose deprivation in PC12 cells. Molecules 2012, 17:315-327.
54. Mukerji S.S., Katsman E.A., Wilber C., et al. Activin is a neuronal survival factor that is rapidly increased after transient cerebral ischemia and hypoxia in mice. J. Cereb. Blood Flow Metab. 2007, 27:1161-1172.
55. Florio P., Perrone S., Luisi S., et al. Increased plasma concentrations of activin a predict intraventricular hemorrhage in preterm newborns. Clin. Chem. 2006, 52:1516-1521.
56. Florio P., Luisi S., Bruschettini M., et al. Cerebrospinal fluid activin A measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy. Clin. Chem. 2004, 50:2386-2389.
57. Florio P., Luisi S., Moataza B., et al. High urinary concentrations of activin A in asphyxiated full-term newborns with moderate or severe hypoxic ischemic encephalopathy. Clin. Chem. 2007, 53:520-522.
58. Huang H.B., Liu H.Y., Li L. Changes and significances of serum levels of macrophage migrartion inhibitory factor and matrix metalloproteinase-9 in newborn infants with hypoxic-ischemic encephalopathy. Med. Sci. J. Cent. South China 2013, 41:61-66.
59. Liu H,Cheney J,LI X,et al. Changes and clinical significance of serum levels of MMP-9 and MMP-2 in newborns with hypoxic-ischemic encephalopathy. J. Clin. Pediatr. 2009;27:842-43.
60. Jiang C.Y., Song Y., Dang Z.Q. Measurement of serum MMP-9 and IL-6 for neonatal hypoxic ischemic encephalopathy and its clinical significance. Clin. Misdiagnosis Mistherapy 2011, 24:77-78.
61. Liu H.M., Li F.J. Vascular endothelial growth factor and hypoxic ischemic brain damage. Prog. Mod. Biomed. 2009, 9:3576-3584.
62. Liang Y.M., Wang H. The expression of VEGF and VEGF mRNA in hypoxic-ischemic brain injury. Chin. Pediatr. Emerg. Med. 2005, 12:134-136.
63. Feng Y., Rhodes P.G., Bhatt A.J. Neuroprotective effects of vascular endothelial growth factor following hypoxic ischemic brain injury in neonatal rat. Pediatr. Res. 2008, 64:370-374.
64. Tan Y.F., Tang Z.L. Change of vascular endothelial growth factor and nitric oxide levels in plasma and cerebrospinal fluid in newborn with hypoxic-ischemic encephalopathy. Chin. J. Contemp. Pediatr. 2004, 6:385-387.
65. Shi X., Li Y.Z., Wei J.K., Du C.J., Chou G.C. Dynamic change of serum levels of vascular endothelial growth factor in newborn infant with hypoxic-ischemic encephalopathy and their clinical significance. Chin. J. Appl. Clin. Pediatr. 2006, 21(12):749-750.
66. Kumar A., Mittal R., Khanna H.D., et al. Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy. Pediatrics 2008, 122:e722-e727.
67. Kumar A., Ramakrishna S.V., Basu S., et al. Oxidative stress in perinatal asphyxia. Pediatr. Neurol. 2008, 38:181-185.
68. Mondal N., Bhat B.V., Banupriya C., et al. Oxidative stress in perinatal asphyxia in relation to outcome. Indian J. Pediatr. 2010, 77:515-517.
69. Wan Z.T., Wang W.X., Lu H.Y., Zhou Y.X. Relationship between serum MDA level and brain CT value in neonatal hypoxic ischemic encephalopathy (HIE). Chin. J. Child Health Care 2001, 9:3-4.
70. Cun Y.C., Liu C.Q., Li L., et al. A study on the duration of head-cooling -induced hypothermia on the prognosis of moderate-severe neonatal hypoxic-ischemic encephalopathy. Chin. J Neonatol. 2012, 27:153-156.
71. Wang J.X., Wang H.Y., Zhang Y.M., et al. Effect of erythropoiet on serum SOD, MDA in neonatal hypoxic ischemic encephalopathy 2009, 24:4236-4238.
72. Qin L.N., Feng A.H., Yang C.H., et al. Clinical values of superoxide dismutase and malondialdehyde detection in cord blood of newborns with fetal distress. Chin. J. Obstet. Gynecol. 2005, 40:312-314.
73. Liu F.D., Mccullough L.D. Inflammatory responses in hypoxic ischemic encephalopathy. Acta Pharmacol. Sin. 2013, 34:1121-1130.
74. Shang Y., Mu L., Guo X., Li Y., Wang L., Yang W., Li S., Shen Q. Clinical significance of interleukin-6, tumor necrosis factor-α and high-sensitivity C-sensitivity C-reactive protein in neonates with hypoxic-ischemic encephalopathy. Exp. Ther. Med. 2014, 8:1259-1262.
75. Tian J.C., Yan S.T. determination and clinical significance of serum hs-CRP, TNF-a, MMP-9 in Neonatal hypoxic ischemic encephalopathy. China Mod. Med. 2012, 19:92-93.
76. Saliba E., Henrot A. Inflammatory mediators and neonatal brain damage. Biol. Neonate 2001, 79:224-227.
77. Liu J., Feng Z.C. Increased umbilical cord plasma interleukin-1 beta levels was correlated with adverse outcomes of neonatalhypoxic-ischemic encephalopathy. J. Trop. Pediatr. 2010, 56:178-182.
78. Aly H., Khashaba M.T., EI-Ayouty M., et al. IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev. 2006, 28:178-182.
79. Chiesa C., Pellegrini G., Panero A., et al. Umbilical cord interleukin-6 are elevated in term neonates with perinatal asphyxia. Eur. J. Clin. Investig. 2003, 33:352-358.
80. Wu X.P., Zhang L.X., Shen Y.J., et al. Relationship between serum inflammatory factors and neonatal brain injury. Chin. J. Neonatol. 2012, 27:180-182.
81. Lu F., Yang M.H., Qian Z.X. Clinical Changes significance of change of serum interleukin-8 and interleukin -10 level in neonatal hypoxic ischemic encephalopathy. Heilongjiang Med. J. 2009, 33:641-643.
82. Youn Y.A., Kim S.J., Sung I.K., et al. Serial examination of serum IL-8, IL-10 and IL-1Ra levels is significant in neonatal seizures induced by hypoxic-ischaemic encephalopathy. Scand. J. Immunol. 2012, 76:286-293.
83. Wang Y.C., Shi C.C., Ni H. Clinical significance of serum interleukin 10 levels in neonatal hypoxic ischemic encephalopathy. J. Appl. Clin. Pediatr. 2003, 18:442-443.
84. Róka A., Bekǒ G., Halósz J., et al. Changes in serum cytokine and cortisol levels in normothermic and hypothermic term neonates after perinatal asphyxia. Inflamm. Res. 2013, 62:81-87.
85. Felderhoff-Mueser U., Ol S., Oberholzer A., et al. IL-18: a key player in neuroinflammation and neurodegeneration. Trends Neurosci. 2005, 28:487-493.
86. Guo J., Wang G.T., Lin L., et al. The changes of serum IL-18,IL-6 and IFN-r in newborns with hypoxic-ischemic encephalopathy. J. Xiangnan Univ. (Med. Sci.) 2014, 16:11-13.
87. Guo Y.H., Li G.X., Li W.H., Liu Z.S., Bai X.M. Dynamic study of serum interleukin 18 levels in neonatal hypoxic ischemic encephalopathy. J. Hebei Med. Univ. 2014, 35:1337-1339.
88. Yuan EW, YU WQ, Yang M, et al. Detection and clincal significance of IL-18 and neuron-specific enolase is serum of newborns with hypoxic-ischemic encephalopathy. Chin. J Neonatol. 2009;24:105-08.
89. Oygür N., Sǒnmez O., Saka O., et al. Predictive value of plasma and cerebrospinal fluid tumour necrosis factor-alpha and interleukin-1 beta concentrations on outcome of full term infants with hypoxic-ischaemic encephalopathy. Arch. Dis. Child. Fetal Neonatal. 1998, 79:F190-F193.
90. Silveura R.C., Procianoy R.S. Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J. Pediatr. 2003, 143:625-629.
91. Ceccon M.E. Interleukins in hypoxic-ischemic encephalopathy. J. Pediatr. 2003, 79:280-281.
92. Wang C.Q. Investigation on the changes of TNF-a in neonatal hypoxic ischemic encephalopathy. Matern. Child Health Care China 2010, 25:543-545.
93. Kim Y.S., Part G.B., Song H.K., et al. Cross-linking of cd54 on Burkitt lymphoma cell line Raji and Ramos induces FasL expression by reactive oxygen species and apoptosis of adjacent cells in Fas/FasL interation. Immunotherapy 2007, 30:727-739.
94. Guo W.Y., Li R.S., Wang W., Dong D.B., Wang A.Y. Expression and clinical significance of solubility sICAM-1 in newborns with hypoxic-ischemic encephalopathy. Prog. Mod. Biomed. 2011, 11:3135-3137.
95. Yi B, Liu KL, Shen H. Changes of serum sICAM-1 and NSE levels in hypoxic ischemic encephalopathy. Shandong Med. J. 2014;54:54-55.
96. Huseynova S., Panakhova N., Oruiova P., et al. Elevated levels of serum slCAM-1 in asphyxiated low birth weight newborns. Sci. Rep. 2014, 4:6850.
97. Ley K., Bullard D.C., Arbones M.L., et al. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J. Exp. Med. 1995, 181:669-675.
98. Grosshaupt B., Muntean W., Sedlmayr P. Hyporeactivity of neonatal platelets is not caused by preactivation during birth. Eur. J. Pediatr. 1997, 156:944-948.
99. Rebuck N., Gibson A., Finn A. Neutrophil adhesion molecules in term and premature infants: normal or enhanced leucocyte integrins but defective L-selectin expression and shedding. Clin. Exp. Immunol. 1995, 101:183-189.
100. Sun Y.Z., Lv J.Y. Dynamic changes and significance serum P- selectin in neonatal hypoxic ischemic encephalopathy. Shandong Med. J. 2007, 47:101-102.
101. Cheng D.J., Qin G.X., Zhang X.L. The changes and significance serum soluble cell adhesion molecule -1 and P- selectin in neonatal hypoxic ischemic encephalopathy. Chin. J. Perinat. Med. 2006, 5:199-200.
102. Song J.Z., Zhou Z.Y., Li Z.G., et al. The significance of lymphocyte L-selectin and ICAM-1 levels in newborns with hypoxic-ischemic encephalopathy. Chin. J. Neonatol. 2008, 23:75-77.
103. Zhang J.X., Dong L. detection of serum LDH in neonatal encephalopathy. J Inner Monglia Med. Univ. 2015, 37:72-73.
104. Hayakawa M., Ito Y., Saito S., et al. Incidence and prediction of outcome in hypoxic-ischemic encephalopathy in Japan. Pediatr. Int. 2014, 56:215-221.
105. Beken S., Aydin B., Dilli D., et al. Can biochemical markers predict the severity of hypoxic-ischemic encephalopathy?. Turk. Pediatr. 2014, 56:62-68.
106. Streijger F., Oerlemans F., Ellenbroek B.A., et al. Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit. Brain Res. 2005, 157:219-234.
107. Walsh P., Jedeikin R., Ellis G., et al. Assessment of neurologic outcome in asphyxiated term infants by use of serial CK-BB isoenzyme measurement. J. Pediatr. 1982, 101:988-992.
108. Fernandez F., Verdu A., Quero J., et al. Serum CPK-BB isoenzyme in the assessment of brain damage in asphyctic term infants. Acta Paediatr. Scand. 1987, 76:914-918.
109. Sweet D.G., Bell A.H., McClure G., et al. Comparison between creatine kinase brain isoenzyme(CCBB) activity and Sarnat score for prediction of adverse outcome following perinatal asphyxia. J. Perinat. Med. 1999, 27:478-483.
110. Nagdyman N., Grimmer I., Scholz T., et al. Predictive value of brain-specific proteins in serum for neurodevelopmental outcome after birth asphyxia. Pediatr. Res. 2003, 54:270-275.
111. Yao B.Z., Xia L.P., Huang X.Y., Tang H.M., Jiang Z.Y. Dynamic observation of serum enolase enzyme, creatine kinase and brain type isoenzyme in neonatal hypoxic ischemic encephalopathy. Chin. J. Pract. Pediatr. 2004, 19:363-364.
112. Zhang A.M., Liu C.Y., Lv Z.F., Duan Q.J. Correlation between serum CK-BB and cerebral CT value in asphyxiated term infant with hypoxic-ischemic encephalopathy. Chin. J. Birth Health Hered. 2006, 14:90-92.
113. Gücüyener K., Atalay Y., Aral Y.Z., et al. Excitatory amino acids and taurine levels in cerebrospinal fluid of hypoxic-ischemic encephalopathy in newborn. Clin. Neurol. Neurosurg. 1999, 101:171-174.
114. Pu Y., Li Q.F., Zeng C.M., et al. Increased detectability of alpha brain glutamate glutamine in neonatal hypoxic-ischemic encephalopathy. AJNR Am. Neuroradiol. 2000, 21:203-212.
115. Zhang C.Y., Han H.H., Ge Q.F. Dynamic changes of serum glutamate level in hypoxia-ischemia encephalopathy. China Pract. Med. 2010, 5:3-4.
116. Hagberg H., Thornberg E., Blennow M., et al. Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants: relationship to hypoxic-ischemic encephalopathy. Acta Paediatr. 1993, 82:925-929.